Search Within

Sarah Elizabeth Lochrin

Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. Department of Medicine (6)
  2. Hematologic Malignancies, Division of (6)
  3. Melanoma Disease Management Team (6)
  4. Melanoma and Immunotherapeutics Service (6)
  5. Solid Tumor Oncology Division (6)
  6. Survivorship Research (5)

More Groups

People
  1. Alexander Shoushtari (6)
  2. Michael Postow (5)
  3. Parisa Momtaz (5)
  4. James Smithy (4)
  5. Katherine Panageas (3)
  6. Hannah Kalvin (2)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
Publications
  1. Journal of Clinical Oncology (3)
  2. JAMA Oncology (1)
  3. Melanoma Research (1)
  4. Pigment Cell & Melanoma Research (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Medical Association (1)
  3. Lippincott Williams & Wilkins (1)
  4. Wiley Blackwell (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab
    Journal Article

    Lochrin, S. E.; Buonocore, D. J.; Young, R. J.; Kaley, T. J.; Postow, M. A.; Wolchok, J. D.; Shoushtari, A. N.; Momtaz, P.; Betof Warner, A. S.; Callahan, M. K.
    Pigment Cell & Melanoma Research (2024)

    Fulltext@MSK | Save
  • Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1-resistant mucosal melanoma
    Journal Article

    Lochrin, S. E.; Cugliari, M. K.; Yeh, R.; Shoushtari, A. N.
    Melanoma Research (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Meeting Abstract

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes
    Meeting Abstract

    Lochrin, S. E.; Kemel, Y.; Stuart, J.; Smithy, J. W.; Mandelker, D.; Momtaz, P.; Chatila, W. K.; Schultz, N.; Postow, M. A.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save